MANA RBM's network of clinical researchers reported that research sites are eliminating onsite monitoring visits. If onsite monitoring visits are a Sponsor's main oversight approach, the solution to this critical problem is available now.
MANA RBM provides remote, automated risk-based monitoring (RBM) customized to a site's protocol. The company delivers its solution, customized to the areas of greatest concern, specific to a study. Subject review can begin within days.
"We recently published an example of this successful approach, adding remote Risk Based Monitoring to trials being conducted with traditional SDV," said Penny Manasco, M.D., CEO of MANA RBM. "Within days, we started remote subject review. Within 2 months, we identified critical errors that SDV did not find."
Here is the link to the head to head comparison:
http://www.appliedclinicaltrialsonline.com/comparing-risk-based-monitoring-and-remote-trial-management-vs-sdv
March 17, 2020
Topic Area: Press Release
Recent Posts
Building Sustainable Healthcare for an Aging Population
Traditional responses — building more primary and secondary care facilities — are no longer sustainable.
Froedtert ThedaCare Announces Opening of ThedaCare Medical Center-Oshkosh
The organization broke ground on the health campus in March 2024.
Touchmark Acquires The Hacienda at Georgetown Senior Living Facility
The facility will now be known as Touchmark at Georgetown.
Contaminants Under Foot: A Closer Look at Patient Room Floors
So-called dust bunnies on hospital room floors contain dust particles that turn out to be the major source of the bacteria humans breathe.
Power Outages Largely Driven by Extreme Weather Events
Almost half of power outages in the United States were caused by extreme weather events.